BA
52
2
HRL
39
15
CSCO
63
2
EQT
59
2
L
62
2
CMCSA
48
2
AKAM
43
3
URBN
38
-4
ACN
47
-2
ZBH
60
-2
AFL
46
-3
UPS
41
-4
BEN
45
3
NI
75
2
RRC
63
3
SIG
43
3
LUV
39
-5
KMX
58
3
STI
47
-12
IBM
54
4
BA
52
2
HRL
39
15
CSCO
63
2
EQT
59
2
L
62
2
CMCSA
48
2
AKAM
43
3
URBN
38
-4
ACN
47
-2
ZBH
60
-2
AFL
46
-3
UPS
41
-4
BEN
45
3
NI
75
2
RRC
63
3
SIG
43
3
LUV
39
-5
KMX
58
3
STI
47
-12
IBM
54
4
Financhill
Back

Cartesian Therapeutics Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
26

RNAC
Cartesian Therapeutics

Last Price:
16.58
Seasonality Move:
13.13%
Sell
23

ALNY
Alnylam Pharmaceuticals

Last Price:
246.88
Seasonality Move:
10.85%
Sell
26
Cartesian Therapeutics (RNAC) is a Sell

Is Cartesian Therapeutics a Buy, Sell or Hold?

  • The current Cartesian Therapeutics [RNAC] share price is $16.94. The Score for RNAC is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • RNAC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $246.80. The Score for ALNY is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RNAC Stock Price Chart

What is Cartesian Therapeutics's stock price today?

  • The Cartesian Therapeutics share price today is $16.94
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNAC is experiencing selling pressure, which indicates risk of future bearish movement.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $246.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing slight selling pressure.

RNAC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.75 Sell
Relative Strength Index (14 RSI): 39.42 Sell
Chaikin Money Flow: -99129 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -9.62 Sell
Relative Strength Index (14 RSI): 38.74 Sell
Chaikin Money Flow: -304936 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (252.02 - 290.24) Sell
Bollinger Bands (100): (248.77 - 281.71) Sell

RNAC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.66 Sell
20-day SMA: 19.51 Sell
50-day SMA: 19.31 Sell
200-day SMA: 20 Sell
8-day EMA: 17.92 Sell
20-day EMA: 18.95 Sell
50-day EMA: 19.03 Sell
200-day EMA: 21.01 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 248.63 Sell
20-day SMA: 265.26 Sell
50-day SMA: 272.83 Sell
200-day SMA: 211.25 Buy
8-day EMA: 249.36 Sell
20-day EMA: 260.88 Sell
50-day EMA: 266.13 Sell
200-day EMA: 230.89 Buy

Cartesian Therapeutics Earnings Growth & RNAC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.90 per share, and an increase next year of $1.70 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.46 per share, and an increase next year of $0.61 per share.

Cartesian Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):